Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 312
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599

Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d

Ferrada, E, Wiedmer, T, Wang, WA, Frommelt, F, Steurer, B, Klimek, C, Lindinger, S, Osthushenrich, T, Garofoli, A, Brocchetti, S, Bradberry, S, Huang, J, MacNamara, A, Scarabottolo, L, Ecker, GF, Malarstig, A & Superti-Furga, G 2024, 'Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8', Journal of Molecular Biology, vol. 436, no. 2, 168383. https://doi.org/10.1016/j.jmb.2023.168383

Activities

Prediction of ligands of promiscuous targets - safety sciences on the molecular level

Gerhard Ecker
BIT's 6th Annual Congress of International Drug Discovery Science and Technology
Conference, Talk or oral contribution
20.10.2008 - 20.10.2008

Optimizing Ligands for Promiscuous Targets - A Case Study for P-glycoprotein Inhibitors

Gerhard Ecker
SFB-Symposium 08
Conference, Talk or oral contribution
26.9.2008 - 26.9.2008

Pharmacoinformatic approaches to target polyspecific proteins

Gerhard Ecker
Summer School on Molecular Modeling and Drug Design
Summer/Winter school, Talk or oral contribution
13.9.2008 - 13.9.2008

Use your brain - artificial neural networks in drug discovery

Gerhard Ecker
Summer School on Molecular Modeling and Drug Design
Summer/Winter school, Talk or oral contribution
12.9.2008 - 12.9.2008

EUROPIN - A European Pharmacoinformatics Initative

Gerhard Ecker
New Perspectives for Higher Education Institutions: The centralised Erasmus activities in the EU Program for Life Long Learning
Seminar/Workshop, Talk or oral contribution
4.7.2008 - 4.7.2008